MORGAN STANLEY PLC/PUT/SANOFI/80/0.1/20.12.24 Share Price

Warrant

DE000MB31WU5

Market Closed - Börse Stuttgart 10:08:42 05/07/2024 pm IST
0.174 EUR -1.69% Intraday chart for MORGAN STANLEY PLC/PUT/SANOFI/80/0.1/20.12.24
Current month-5.43%
1 month+1.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart SANOFI
Chart MORGAN STANLEY PLC/PUT/SANOFI/80/0.1/20.12.24
Date Price Change
05/24/05 0.174 -1.69%
04/24/04 0.177 +0.57%
03/24/03 0.176 -2.22%
02/24/02 0.18 +16.13%
01/24/01 0.155 -15.76%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 10:08 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying SANOFI
Issuer Morgan Stanley
WKN MB31WU
ISINDE000MB31WU5
Date issued 31/01/2023
Strike 80
Maturity 20/12/2024 (166 Days)
Parity 10 : 1
Emission price 0.87
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.95
Lowest since issue 0.137
Delta-0.18x
Omega 9.403
Premium13.99x
Gearing50.95x
Moneyness 0.8797
Difference Strike -10.94
Difference Strike %-13.68%
Spread 0.011
Spread %5.98%
Theoretical value 0.1785
Implied Volatility 26.36 %
Total Loss Probability 76.42 %
Intrinsic value 0.000000
Present value 0.1785
Break even 78.22 €
Theta-0.01x
Vega0.02x
Rho-0.01x

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
90.94 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.86%
Consensus